Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation

J Herrmann1, M Haude, A Lerman

  • 1Department of Cardiology, University Clinic Essen, Essen, Germany.

Circulation
|May 23, 2001
PubMed

Insights

Reduced coronary flow velocity reserve after stenting often indicates microvascular impairment. This study shows reduced rCVR is linked to cardiac enzyme elevation, suggesting microvascular injury from embolization during coronary procedures.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Microvascular Physiology

Background:

  • Reduced relative coronary flow velocity reserve (rCVR) post-coronary intervention is linked to microvascular impairment.
  • The incidence of cardiac enzyme elevation as a marker of embolic myocardial injury in these cases remains understudied.

Purpose of the Study:

  • To investigate the incidence of cardiac enzyme elevation (creatine kinase and troponin T) after successful coronary stenting.
  • To determine the correlation between postprocedural rCVR and cardiac enzyme elevation.
  • To identify a cutoff value for rCVR to predict myocardial injury.

Main Methods:

  • 55 patients undergoing successful coronary stenting with periprocedural intracoronary Doppler analysis were studied.
  • Creatine kinase (CK) and cardiac troponin T (cTnT) levels were measured before and up to 24 hours post-intervention.
  • Correlation and receiver operating characteristic (ROC) analyses were performed to assess the relationship between rCVR and enzyme elevation.

Main Results:

  • Postprocedural rCVR independently correlated with cTnT (r=-0.498, P<0.001) and CK elevation (r=-0.406, P=0.002).
  • An rCVR cutoff of 0.78 best discriminated cTnT and CK elevation (sensitivity 83.3%/69.2%, specificity 79.1%/76.2%).
  • Patients with rCVR <0.78 had significantly higher rates of cTnT (52.6%) and CK (36.8%) elevation compared to those with rCVR ≥0.78 (5.6% for both, P<0.001).

Conclusions:

  • Cardiac marker elevation is frequent after coronary procedures associated with reduced rCVR.
  • Persistent reduction in rCVR suggests procedural embolization of atherothrombotic debris.
  • Microvascular impairment and myocardial injury are potential underlying mechanisms for enzyme elevation post-intervention.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495